Assessment of the timing of histologic and molecular testing indicates that testing occurred prior to treatment initiation for most patients with metastatic non—small cell lung cancer.
Gregory Smith, BA
Advertisement
Articles by Gregory Smith, BA
Advertisement
Latest Updated Articles
- Molecular Testing Patterns in Metastatic Non—Small Cell Lung Cancer
February 3rd 2016
Advertisement
Advertisement
Trending on AJMC
1
FDA Advisory Panel Weighs Access to 7 Popular Peptides This Week
2
Impact of Automated Insulin Delivery on Type 2 Diabetes Measures
3
Eplontersen Misses Primary End Point in Phase 3 ATTR-CM Cardiovascular Outcomes Trial
4
Dermatology Practices Absorb Rising Prior Authorization Costs
5